GlassScriptPhysician profile
Latricia M Thompson
NPI 1952533168
$1,957.89
in general payments reported to CMS, 2019-2025
36 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $47.32 · 2021: $72.71 · 2022: $342 · 2023: $503 · 2024: $539 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $237.68 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $219.82 | 2023-2024 | Myfembree |
| Medtronic, INC. | $149.39 | 2022 | |
| Evofem Biosciences, INC. | $125.40 | 2022-2024 | Phexxi |
| Baxter Healthcare | $107.53 | 2023-2024 | Perclot, Tisseel |
| Abbvie INC. | $97.87 | 2019-2023 | Lo Loestrin Fe |
| Ethicon US, LLC | $97.74 | 2019-2024 | Enseal |
| Mayne Pharma Commercial LLC | $76.66 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.60 | 2022-2023 | |
| Myovant Sciences INC. | $69.90 | 2022 | |
| Applied Medical Resources Corporation | $56.99 | 2021 | |
| Zyla Life Sciences, INC. | $55.25 | 2019 | |
| Smith+Nephew, INC. | $52.08 | 2024-2025 | Pico 7 |
| Pfizer INC. | $45.15 | 2024 | |
| Coopersurgical, INC. | $45.11 | 2019-2023 | Advincula Delineator Uterine Manipulator |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $38.41 | 2019 | |
| Shield Therapeutics INC | $37.54 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $31.89 | 2025 | Aptima |
| Organon LLC | $31.38 | 2024-2025 | Jada System |
| Exeltis, USA INC. | $26.97 | 2020-2023 | Slynd |
| Biogen, INC. | $25.55 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $23.00 | 2019 | |
| Novo Nordisk INC | $22.72 | 2020 | |
| Avion Pharmaceuticals | $22.64 | 2023 | Balcoltra |
| Aspira Women'S Health INC | $21.49 | 2024 | Ova1 |
| Duchesnay USA Incorporated | $21.46 | 2019 | |
| Davol INC. | $18.11 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.77 | 2024 | |
| Meditrina | $16.19 | 2022 | |
| Acerus Pharmaceuticals Corporation | $15.72 | 2021 | |
| Allergan, INC. | $15.43 | 2019 | |
| Olympus America INC. | $13.68 | 2019 | |
| Merck Sharp & Dohme LLC | $12.72 | 2020 | |
| Therapeuticsmd, INC. | $11.19 | 2019 | |
| Lupin INC. | $10.95 | 2019 | |
| Vertical Pharmaceuticals, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latricia Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.